Vor Bio is bowing out amid a tough funding environment after examining the clinical data currently available for its assets. The company will let go of 147 employees, or 95% of its staff, and expects to complete the layoffs by the end of the second quarter, according to an SEC filing.
All entries for: Vor Bio
May 9, 2025
Vor Bio
Layoffs
Cambridge, MA
51-200 employees
Disease Area: Hematology, Immune Diseases, Multiple
Drug Type: Biologic